pcDNA™4/TO Mammalian Expression Vector
Product Image
Invitrogen™

pcDNA™4/TO Mammalian Expression Vector

ウイルス転写活性化因子なしのテトラサイクリンで制御された哺乳類発現システムT-REx™Systemは、他のどの制御された哺乳類発現システムよりも高レベルの誘導発現をもたらします。完全なCMVプロモーターを利用し、細菌のテトラサイクリン耐性オペロンの制御要素を追加して、既知の最も強力な哺乳類プロモーター配列(1,2)のいずれかから転写を効果的に抑制したり抑制を解除したりします。特異的な活性化T-REX™ Systemは、テトラサイクリンが存在しない場合に、強力なCMVプロモーターからの転写をブロックするリプレッサーメカニズムを使用します。T-REx™詳細を見る
製品番号(カタログ番号)数量
V102020
または、製品番号V1020-20
20 μg
製品番号(カタログ番号) V102020
または、製品番号V1020-20
価格(JPY)
80,200
Online offer
Ends: 27-Mar-2026
114,700
割引額 34,500 (30%)
20 µg
お問い合わせください ›
数量:
20 μg
ウイルス転写活性化因子なしのテトラサイクリンで制御された哺乳類発現システム
T-REx™Systemは、他のどの制御された哺乳類発現システムよりも高レベルの誘導発現をもたらします。完全なCMVプロモーターを利用し、細菌のテトラサイクリン耐性オペロンの制御要素を追加して、既知の最も強力な哺乳類プロモーター配列(1,2)のいずれかから転写を効果的に抑制したり抑制を解除したりします。

特異的な活性化
T-REX™ Systemは、テトラサイクリンが存在しない場合に、強力なCMVプロモーターからの転写をブロックするリプレッサーメカニズムを使用します。T-REx™ Systemの要素はウイルス転写活性化因子を使用しないため、宿主遺伝子の二次的で非特異的な活性化を行うことなく、完全なCMVプロモーターからの高レベルの発現を実現できます。

T-REX™ メカニズム
T-REX™転写コントロール要素を図1に示します。CMVプロモーターのTATAボックスと転写開始部位の間に挿入された2つのテトラサイクリンオペレーター配列(TetO2)によって提供されます。TetO2配列自体は発現に影響しません。テトラサイクリンリプレッサータンパク質(TR)が存在する場合、TetO2部位を効果的に結合し、転写開始をブロックします。培養培地に添加されたテトラサイクリンは、TRタンパク質と結合し、その立体構造を変化させます。TRタンパク質はTetO2部位を解放し、CMVプロモーターからの転写を抑制します。その結果、目的遺伝子の高レベル発現が実現します(図2)。発現レベルはテトラサイクリン濃度に基づいて調節でき、構成的なCMV発現ベクターで実現されるレベルに誘導できます。
T-REx™は強力な誘導性哺乳類発現システムで、完全なヒトサイトメガロウイルス(CMV)エンハンサープロモーターからの発現を調節できます。T-RE™誘導性発現ベクターには、以下の特長があります。

•高レベルでの調節される発現用のテトラサイクリンオペレーターTetO2配列の2つコピーを含む完全なCMVエンハンサー-プロモーター配列
•安定した哺乳類細胞株を効果的に選択するための、ゼオシン™またはハイグロマイシン耐性遺伝子
•クローニングを簡素化する大規模な複数のクローニング部位

さらに、pcDNA™4/TO/myc-Hisは、抗myc抗体を用いた組換えタンパク質の迅速な検出のためのc-mycエピトープと、ニッケルキレート樹を用いた組換えタンパク質のシンプルな浄化のためのポリヒスチジン(6xHis)配列および脂および抗His(C-term)抗体を用いた検出を提供します。

テトラサイクリンリプレッサー(TR)タンパク質の高レベルでの発現用に、調節ベクター、pcDNA™6/TRが提供されています。このベクターは、TRタンパク質を安定的に発現する哺乳類細胞株を迅速に選択するために、ブラストサイジン耐性遺伝子を発現します。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
構成または誘導システム誘導型
供給タイプTransfection
使用対象(アプリケーション)調節される発現
誘導試薬テトラサイクリン
製品タイプ哺乳類発現用ベクター
数量20 μg
選択剤(真核生物)ゼオシン™
ベクターpcDNA
クローニング法制限酵素/MCS
製品ラインT-REx、pcDNA, pcDNA
プロモーターCMV/TO
タンパク質タグタグなし
Unit Size20 µg

よくあるご質問(FAQ)

I performed stable selection but my antibiotic-resistant clones do not express my gene of interest. What could have gone wrong?

Here are possible causes and solutions:

Detection method may not be appropriate or sensitive enough:
- We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot.
- Insufficient number of clones screened: Screen at least 20 clones.
- Inappropriate antibiotic concentration used for stable selection: Make sure the antibiotic kill curve was performed correctly. Since the potency of a given antibiotic depends upon cell type, serum, medium, and culture technique, the dose must be determined each time a stable selection is performed. Even the stable cell lines we offer may be more or less sensitive to the dose we recommend if the medium or serum is significantly different.
- Expression of gene product (even low level) may not be compatible with growth of the cell line: Use an inducible expression system.
- Negative clones may result from preferential linearization at a vector site critical for expression of the gene of interest: Linearize the vector at a site that is not critical for expression, such as within the bacterial resistance marker.

I used a mammalian expression vector but do not get any expression of my protein. Can you help me troubleshoot?

Here are possible causes and solutions:

- Try the control expression that is included in the kit
Possible detection problem:

- Detection of expressed protein may not be possible in a transient transfection, since the transfection efficiency may be too low for detection by methods that assess the entire transfected population. We recommend optimizing the transfection efficiency, doing stable selection, or using methods that permit examination of individual cells. You can also increase the level of expression by changing the promoter or cell type.
- Expression within the cell may be too low for the chosen detection method. We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot. Protein might be degraded or truncated: Check on a Northern. Possible time-course issue: Since the expression of a protein over time will depend upon the nature of the protein, we always recommend doing a time course for expression. A pilot time-course assay will help to determine the optimal window for expression. Possible cloning issues: Verify clones by restriction digestion and/or sequencing.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I am using a mammalian expression vector that has the neomycin resistance gene. Can I use neomycin for stable selection in mammalian cells?

No; neomycin is toxic to mammalian cells. We recommend using Geneticin (a.k.a. G418 Sulfate), as it is a less toxic and very effective alternative for selection in mammalian cells.

Is it okay if my construct has an ATG that is upstream of the ATG in my gene of interest? Will it interfere with translation of my gene?

Translation initiation will occur at the first ATG encountered by the ribosome, although in the absence of a Kozak sequence, initiation will be relatively weak. Any insert downstream would express a fusion protein if it is in frame with this initial ATG, but levels of expressed protein are predicted to be low if there is a non-Kozak consensus sequence. If the vector contains a non-Kozak consensus ATG, we recommend that you clone your gene upstream of that ATG and include a Kozak sequence for optimal expression.

Do you offer a GFP-expressing mammalian expression vector that I can use as a control to monitor my transfection and expression?

We offer pJTI R4 Exp CMV EmGFP pA Vector, Cat. No. A14146, which you can use to monitor your transfection and expression.

引用および参考文献 (5)

引用および参考文献
Abstract
Retention of mutant low density lipoprotein receptor in ER leads to ER stress.
Authors:Sørensen S, Ranheim T, Bakken KS, Leren TP, Kulseth MA,
Journal:J Biol Chem
PubMed ID:16257961
Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the gene encoding the low density lipoprotein receptor (LDLR). More than 50% of these mutations lead to receptor proteins that are completely or partly retained in the endoplasmic reticulum (ER). The mechanisms involved in the intracellular processing and ... More
BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts.
Authors:Sarig R, Zaltsman Y, Marcellus RC, Flavell R, Mak TW, Gross A,
Journal:J Biol Chem
PubMed ID:12519725
The proapoptotic activity of BID seems to solely depend upon its cleavage to truncated tBID. Here we demonstrate that expression of a caspase-8 non-cleavable (nc) BID-D59A mutant or expression of wild type (wt) BID induces apoptosis in Bid -/-, caspase-8 -/-, and wt primary MEFs. Western blot analysis indicated that ... More
Cell Cycle Regulation and p53 Activation by Protein Phosphatase 2Calpha.
Authors:Ofek P, Ben-Meir D, Kariv-Inbal Z, Oren M, Lavi S,
Journal:J Biol Chem
PubMed ID:12514180
Protein phosphatase 2C (PP2C) dephosphorylates a broad range of substrates, regulating stress response and growth-related pathways in both prokaryotes and eukaryotes. We now demonstrate that PP2Calpha, a major mammalian isoform, inhibits cell growth and activates the p53 pathway. In 293 cell clones, in which PP2Calpha expression is regulated by a ... More
The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus.
Authors: Gao Y; Pimplikar S W;
Journal:Proc Natl Acad Sci U S A
PubMed ID:11742091
Sequential processing of the amyloid precursor protein (APP) by beta- and gamma-secretases generates the Abeta peptide, a major constituent of the senile plaques observed in Alzheimer's disease. The cleavage by gamma-secretase also results in the cytoplasmic release of a 59- or 57-residue-long C-terminal fragment (Cgamma). This processing resembles regulated intramembrane ... More
ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint.
Authors: Nghiem Paul; Park Peter K; Kim Ys Yong-son; Desai Bimal N; Schreiber Stuart L;
Journal:J Biol Chem
PubMed ID:11711532
ATR (ataxia telangiectasia and Rad-3-related) is a protein kinase required for survival after DNA damage. A critical role for ATR has been hypothesized to be the regulation of p53 and other cell cycle checkpoints. ATR has been shown to phosphorylate p53 at Ser(15), and this damage-induced phosphorylation is diminished by ... More